Dr.HeidiM.Mansour - Revision history

Dr. Heidi M. Mansour: /* Journal Publications Corresponding Author */

Dr. Heidi M. Mansour — Fri, 24 May 2013 02:00:18 GMT

Journal Publications *Corresponding Author*

←Older revision		Revision as of 02:00, 24 May 2013
Line 235:		Line 235:
	42. Hayes, D. Jr., Baker, P.B., '''Mansour, H.M.''', Peeples, M.E., and Nicol, K.K. ''Interstitial Lung Disease in a Child with Antisynthetase Syndrome.'' [[Lung]] (2013): ''(''in press'')'' (Impact Factor: 1.99)[http://link.springer.com/article/10.1007%2Fs00408-013-9468-2]		42. Hayes, D. Jr., Baker, P.B., '''Mansour, H.M.''', Peeples, M.E., and Nicol, K.K. ''Interstitial Lung Disease in a Child with Antisynthetase Syndrome.'' [[Lung]] (2013): ''(''in press'')'' (Impact Factor: 1.99)[http://link.springer.com/article/10.1007%2Fs00408-013-9468-2]

-	43. '''Mansour, H.M.''' ~~and Hayes~~, D. Jr.''~~Inhalable Phospholipid and Lipopolymeric Self-Assemblies for Targeted Pulmonary Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Invited Paper~~.'' [[~~Pharmaceutics: Special Issue: Liposomal Technologies~~ ]] (2013)[~~http~~:~~//www.mdpi~~.~~com/journal/pharmaceutics/special_issues/liposome_technologies#planned~~]	+	43.Hayes, D. Jr., Daniels, C.J., '''Mansour, H.M.''', Kopp, B.T., Yates, A.R., McCoy, K.S., Patel, A.V., and Kirby, S. ''Right Heart Catherization Measuring Central Hemodynamics in Cystic Fibrosis During Exercise.'' [[Respiratory Medicine]] (2013): ''(''in press'')'' [Impact Factor: 2.475]

-	44. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.''' ''Characterization and Aerosol Dispersion Performance of Advanced Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lung Cancer.'' [[European Journal of Pharmaceutical Sciences]] (2013) (in press) (Impact Factor: 3.212)[http://www.journals.elsevier.com/european-journal-of-pharmaceutical-sciences/]	+	44. '''Mansour, H.M.''' and Hayes, D. Jr.''Inhalable Phospholipid and Lipopolymeric Self-Assemblies for Targeted Pulmonary Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Invited Paper.'' [[Pharmaceutics: Special Issue: Liposomal Technologies ]] (2013)[http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned]
		+
		+	45. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.''' ''Characterization and Aerosol Dispersion Performance of Advanced Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lung Cancer.'' [[European Journal of Pharmaceutical Sciences]] (2013) (in press) (Impact Factor: 3.212)[http://www.journals.elsevier.com/european-journal-of-pharmaceutical-sciences/]

	==Edited Book (co-Editor)==		==Edited Book (co-Editor)==

Dr. Heidi M. Mansour: /* Book Chapters Corresponding Author */

Dr. Heidi M. Mansour — Fri, 24 May 2013 01:32:49 GMT

Book Chapters *Corresponding Author*

←Older revision		Revision as of 01:32, 24 May 2013
Line 249:		Line 249:
	3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]		3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]

-	4. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing~~/CRC Press~~/Taylor & Francis, Boca Raton, FL, (2013): pp. 1-27. [http://www.routledge.com/books/details/9789814316170]	+	4. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing/Taylor & Francis, Boca Raton, FL, (2013): pp. 1-27. [http://www.routledge.com/books/details/9789814316170]

	5.'''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. [http://www.crcpress.com/product/isbn/9781466506169]		5.'''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. [http://www.crcpress.com/product/isbn/9781466506169]

Dr. Heidi M. Mansour: /* Book Chapters Corresponding Author */

Dr. Heidi M. Mansour — Fri, 24 May 2013 01:31:59 GMT

Book Chapters *Corresponding Author*

←Older revision		Revision as of 01:31, 24 May 2013
Line 249:		Line 249:
	3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]		3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]

-	4. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing/CRC Press/Taylor & Francis, Boca Raton, FL, (~~2012~~): pp. 1-27. [http://www.~~crcpress~~.com/~~product~~/~~isbn~~/9789814316170]	+	4. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing/CRC Press/Taylor & Francis, Boca Raton, FL, (2013): pp. 1-27. [http://www.routledge.com/books/details/9789814316170]

	5.'''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. [http://www.crcpress.com/product/isbn/9781466506169]		5.'''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. [http://www.crcpress.com/product/isbn/9781466506169]

Dr. Heidi M. Mansour: /* Journal Publications Corresponding Author */

Dr. Heidi M. Mansour — Wed, 15 May 2013 12:42:26 GMT

Journal Publications *Corresponding Author*

←Older revision		Revision as of 12:42, 15 May 2013
Line 236:		Line 236:

	43. '''Mansour, H.M.''' and Hayes, D. Jr.''Inhalable Phospholipid and Lipopolymeric Self-Assemblies for Targeted Pulmonary Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Invited Paper.'' [[Pharmaceutics: Special Issue: Liposomal Technologies ]] (2013)[http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned]		43. '''Mansour, H.M.''' and Hayes, D. Jr.''Inhalable Phospholipid and Lipopolymeric Self-Assemblies for Targeted Pulmonary Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Invited Paper.'' [[Pharmaceutics: Special Issue: Liposomal Technologies ]] (2013)[http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned]
		+
		+	44. Meenach, S.A., Anderson, K.W., Hilt, J.Z., McGarry, R.C., and '''Mansour, H.M.''' ''Characterization and Aerosol Dispersion Performance of Advanced Spray-Dried Chemotherapeutic PEGylated Phospholipid Particles for Dry Powder Inhalation Delivery in Lung Cancer.'' [[European Journal of Pharmaceutical Sciences]] (2013) (in press) (Impact Factor: 3.212)[http://www.journals.elsevier.com/european-journal-of-pharmaceutical-sciences/]

	==Edited Book (co-Editor)==		==Edited Book (co-Editor)==

Dr. Heidi M. Mansour: /* Meeting Abstracts selected from 2006-Present (over 30 abstracts prior to 2006)Presenting Author */

Dr. Heidi M. Mansour — Tue, 14 May 2013 01:29:55 GMT

Meeting Abstracts selected from 2006-Present (over 30 abstracts prior to 2006)*Presenting Author*

←Older revision		Revision as of 01:29, 14 May 2013
Line 401:		Line 401:

	36. Meenach, S.A., Tsoras, A.N., McGarry, R.C., '''Mansour, H.M.''' , Hilt, J.Z., and Anderson, K.W. ''Development of Three-Dimensional Lung Multicellular Spheroids for the Evaluation of Anti-Cancer Therapeutics.''[[40th Annual Controlled Release Society Meeting & Exhibition 2013]], Hawaii (July 2013)		36. Meenach, S.A., Tsoras, A.N., McGarry, R.C., '''Mansour, H.M.''' , Hilt, J.Z., and Anderson, K.W. ''Development of Three-Dimensional Lung Multicellular Spheroids for the Evaluation of Anti-Cancer Therapeutics.''[[40th Annual Controlled Release Society Meeting & Exhibition 2013]], Hawaii (July 2013)
		+
		+	37.Stocke, N., Meenach, S.A., Anderson, K.W., Arnold, S., '''Mansour, H.M.''' , and Hilt, J.Z. ''Inhalable Magnetic Nanocomposite Microparticles for Application in Lung Cancer Therapy-In Vitro Safety and Efficacy Studies.'' [[2013 American Institute of Chemical Engineers (AIChE) Annual Meeting & Exhibition]], San Francisco, CA (October 2013)

	'''''UK Meeting Abstracts'''''		'''''UK Meeting Abstracts'''''

Dr. Heidi M. Mansour: /* Editorial Advisory Board Member (EAB) */

Dr. Heidi M. Mansour — Sun, 12 May 2013 18:30:42 GMT

Editorial Advisory Board Member (EAB)

←Older revision		Revision as of 18:30, 12 May 2013
Line 30:		Line 30:
	6. Journal of Pharmaceutical Technology & Drug Research (United Kingdom) [http://www.hoajonline.com/Journal-of-Pharmaceutical-Technology-and-Drug.html]		6. Journal of Pharmaceutical Technology & Drug Research (United Kingdom) [http://www.hoajonline.com/Journal-of-Pharmaceutical-Technology-and-Drug.html]

-	7~~. International Journal of Nano-Studies & Technology [http://www.scidoc.org/editorial_board.php?id=3]~~	+	7. Journal of Molecular Pharmaceutics and Organic Process Research [http://www.esciencecentral.org/journals/editorialboardJMPOPR.php]
-		+
-	8. Journal of Molecular Pharmaceutics and Organic Process Research [http://www.esciencecentral.org/journals/editorialboardJMPOPR.php]	+

	==National Expert Committees==		==National Expert Committees==

Dr. Heidi M. Mansour: /* Research Lab Group Members */

Dr. Heidi M. Mansour — Sat, 11 May 2013 04:41:14 GMT

Research Lab Group Members

←Older revision		Revision as of 04:41, 11 May 2013
Line 305:		Line 305:
	6. Dr. Wei Fen Zhang, M.D., Ph.D., Visiting Professor. Current Position: Associate Professor, School of Pharmaceutical & Biological Science,Weifang Medical University, Shedong, P.R. China.		6. Dr. Wei Fen Zhang, M.D., Ph.D., Visiting Professor. Current Position: Associate Professor, School of Pharmaceutical & Biological Science,Weifang Medical University, Shedong, P.R. China.

-	7. Dr. Scott Silva, Ph.D., M.D.(UK College of Medicine, Major Professor: Dr. Mark Evers),Postdoctoral Physician-Scientist NIH CCTS PSMRF Research Fellow	+	7. Dr. Scott Silva, Ph.D., M.D.(UK College of Medicine, Major Professor: Dr. Mark Evers),Postdoctoral Physician-Scientist NIH CCTS PSMRF Research Fellow. Current Position: Vanderbilt University School of Medicine.

	8. Dr. Sung Gu Han, Ph.D.(UK College of Medicine, Major Professor: Dr. Gary Gairola), Postdoctoral Research Associate.		8. Dr. Sung Gu Han, Ph.D.(UK College of Medicine, Major Professor: Dr. Gary Gairola), Postdoctoral Research Associate.

Dr. Heidi M. Mansour: /* Contact Info */

Dr. Heidi M. Mansour — Sat, 11 May 2013 00:25:55 GMT

Contact Info

←Older revision		Revision as of 00:25, 11 May 2013
Line 1:		Line 1:
-	~~==Contact Info==~~
-	~~Dr. Heidi M. Mansour, Ph.D., R.Ph.~~
-	~~Assistant Professor of Pharmaceutics & Drug Delivery,~~
-	~~Faculty Associate in the UK Center of Membrane Sciences,~~
-	~~UK College of Pharmacy~~
-	~~Dept of Pharmaceutical Sciences-Drug Development~~
-	~~789 South Limestone St.~~
-	~~Lexington, Kentucky 40536-0596.~~

-	~~Telephone: (859) 257-1571; Email: heidi.mansour@uky.edu~~

	==New Contact Info==		==New Contact Info==

Dr. Heidi M. Mansour: /* Journal Publications Corresponding Author */

Dr. Heidi M. Mansour — Fri, 10 May 2013 12:18:40 GMT

Journal Publications *Corresponding Author*

←Older revision		Revision as of 12:18, 10 May 2013
Line 244:		Line 244:
	41. Hayes, D. Jr., Galantowicz, M., Yates, A.R., Preston, T.J., '''Mansour, H.M.''', and McConnell, P.I. ''Venovenous ECMO as a Bridge to Lung Transplant and Protective Strategy for Subsequent Primary Graft Dysfunction.'' [[Journal of Artificial Organs]] (2013): ''(''in press'')'' (Impact Factor: 1.60)[http://link.springer.com/article/10.1007%2Fs10047-013-0699-z]		41. Hayes, D. Jr., Galantowicz, M., Yates, A.R., Preston, T.J., '''Mansour, H.M.''', and McConnell, P.I. ''Venovenous ECMO as a Bridge to Lung Transplant and Protective Strategy for Subsequent Primary Graft Dysfunction.'' [[Journal of Artificial Organs]] (2013): ''(''in press'')'' (Impact Factor: 1.60)[http://link.springer.com/article/10.1007%2Fs10047-013-0699-z]

-	42. Hayes, D. Jr., Baker, P.B., '''Mansour, H.M.''', Peeples, M.E., and Nicol, K.K. ''Interstitial Lung Disease in a Child with Antisynthetase Syndrome.'' [[Lung]] (2013): ''(''in press'')'' (Impact Factor: 1.99)	+	42. Hayes, D. Jr., Baker, P.B., '''Mansour, H.M.''', Peeples, M.E., and Nicol, K.K. ''Interstitial Lung Disease in a Child with Antisynthetase Syndrome.'' [[Lung]] (2013): ''(''in press'')'' (Impact Factor: 1.99)[http://link.springer.com/article/10.1007%2Fs00408-013-9468-2]

	43. '''Mansour, H.M.''' and Hayes, D. Jr.''Inhalable Phospholipid and Lipopolymeric Self-Assemblies for Targeted Pulmonary Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Invited Paper.'' [[Pharmaceutics: Special Issue: Liposomal Technologies ]] (2013)[http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned]		43. '''Mansour, H.M.''' and Hayes, D. Jr.''Inhalable Phospholipid and Lipopolymeric Self-Assemblies for Targeted Pulmonary Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Invited Paper.'' [[Pharmaceutics: Special Issue: Liposomal Technologies ]] (2013)[http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned]

Dr. Heidi M. Mansour: /* Journal Publications Corresponding Author */

Dr. Heidi M. Mansour — Thu, 09 May 2013 15:26:11 GMT

Journal Publications *Corresponding Author*

←Older revision		Revision as of 15:26, 9 May 2013
Line 244:		Line 244:
	41. Hayes, D. Jr., Galantowicz, M., Yates, A.R., Preston, T.J., '''Mansour, H.M.''', and McConnell, P.I. ''Venovenous ECMO as a Bridge to Lung Transplant and Protective Strategy for Subsequent Primary Graft Dysfunction.'' [[Journal of Artificial Organs]] (2013): ''(''in press'')'' (Impact Factor: 1.60)[http://link.springer.com/article/10.1007%2Fs10047-013-0699-z]		41. Hayes, D. Jr., Galantowicz, M., Yates, A.R., Preston, T.J., '''Mansour, H.M.''', and McConnell, P.I. ''Venovenous ECMO as a Bridge to Lung Transplant and Protective Strategy for Subsequent Primary Graft Dysfunction.'' [[Journal of Artificial Organs]] (2013): ''(''in press'')'' (Impact Factor: 1.60)[http://link.springer.com/article/10.1007%2Fs10047-013-0699-z]

-	42. Hayes, D. Jr., Baker, P.B., '''Mansour, H.M.''', Peeples, M.E., and Nicol, K.K. ''Interstitial Lung Disease ~~and Pulmonary Arterial Hypertension~~ in a Child with Antisynthetase Syndrome.'' [[Lung]] (2013): ''(''in press'')'' (Impact Factor: 1.99)	+	42. Hayes, D. Jr., Baker, P.B., '''Mansour, H.M.''', Peeples, M.E., and Nicol, K.K. ''Interstitial Lung Disease in a Child with Antisynthetase Syndrome.'' [[Lung]] (2013): ''(''in press'')'' (Impact Factor: 1.99)

	43. '''Mansour, H.M.''' and Hayes, D. Jr.''Inhalable Phospholipid and Lipopolymeric Self-Assemblies for Targeted Pulmonary Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Invited Paper.'' [[Pharmaceutics: Special Issue: Liposomal Technologies ]] (2013)[http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned]		43. '''Mansour, H.M.''' and Hayes, D. Jr.''Inhalable Phospholipid and Lipopolymeric Self-Assemblies for Targeted Pulmonary Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers. Invited Paper.'' [[Pharmaceutics: Special Issue: Liposomal Technologies ]] (2013)[http://www.mdpi.com/journal/pharmaceutics/special_issues/liposome_technologies#planned]

←Older revision		Revision as of 01:32, 24 May 2013
Line 249:		Line 249:
	3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]		3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]

-	4. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing~~/CRC Press~~/Taylor & Francis, Boca Raton, FL, (2013): pp. 1-27. [http://www.routledge.com/books/details/9789814316170]	+	4. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing/Taylor & Francis, Boca Raton, FL, (2013): pp. 1-27. [http://www.routledge.com/books/details/9789814316170]

	5.'''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. [http://www.crcpress.com/product/isbn/9781466506169]		5.'''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. [http://www.crcpress.com/product/isbn/9781466506169]

←Older revision		Revision as of 01:31, 24 May 2013
Line 249:		Line 249:
	3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]		3. '''Mansour, H.M.''', Rhee, Y.S., Park, C.W., and DeLuca, P.P. ''Book Chapter 9: Lipid Nanoparticulate Drug Delivery and Nanomedicine.'' [[Lipids in Nanotechnology.]] 302 pages. Moghis, A. (Editor), First Edition, American Oil Chemists Society (AOCS) Press, Urbana, Illinois (2011): pp.221-268. [http://www.aocs.org/Store/ProductDetail.cfm?ItemNumber=17612]

-	4. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing/CRC Press/Taylor & Francis, Boca Raton, FL, (~~2012~~): pp. 1-27. [http://www.~~crcpress~~.com/~~product~~/~~isbn~~/9789814316170]	+	4. '''Mansour, H.M.''', Park, C.W., and Bawa, R. ''Book Chapter 6: Design and Development of Approved Nanopharmaceutical Products.'' [[Handbook of Clinical Nanomedicine: From Bench to Bedside]]. Bawa, R., Audette, G., and Rubinstein, I. (Editors),Pan Stanford Publishing/CRC Press/Taylor & Francis, Boca Raton, FL, (2013): pp. 1-27. [http://www.routledge.com/books/details/9789814316170]

	5.'''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. [http://www.crcpress.com/product/isbn/9781466506169]		5.'''Mansour, H.M.''', Park, C.W., and Hayes, D. Jr. ''Book Chapter 3: Nanoparticle Lung Delivery and Inhalation Aerosols for Targeted Pulmonary Nanomedicine.'' [[Nanomedicine in Drug Delivery.]] Kumar, A., '''Mansour, H.M.''', Friedman, A., Blough, E. (Editors), First Edition, CRC Press/Taylor & Francis, Inc., London, United Kingdom. (2013): pp.43-74. [http://www.crcpress.com/product/isbn/9781466506169]

Dr.HeidiM.Mansour - Revision history

Dr. Heidi M. Mansour: /* Journal Publications *Corresponding Author* */

Dr. Heidi M. Mansour: /* Book Chapters *Corresponding Author* */

Dr. Heidi M. Mansour: /* Book Chapters *Corresponding Author* */

Dr. Heidi M. Mansour: /* Journal Publications *Corresponding Author* */

Dr. Heidi M. Mansour: /* Meeting Abstracts selected from 2006-Present (over 30 abstracts prior to 2006)*Presenting Author* */

Dr. Heidi M. Mansour: /* Editorial Advisory Board Member (EAB) */

Dr. Heidi M. Mansour: /* Research Lab Group Members */

Dr. Heidi M. Mansour: /* Contact Info */

Dr. Heidi M. Mansour: /* Journal Publications *Corresponding Author* */

Dr. Heidi M. Mansour: /* Journal Publications *Corresponding Author* */

Dr. Heidi M. Mansour: /* Journal Publications Corresponding Author */

Dr. Heidi M. Mansour: /* Book Chapters Corresponding Author */

Dr. Heidi M. Mansour: /* Book Chapters Corresponding Author */

Dr. Heidi M. Mansour: /* Journal Publications Corresponding Author */

Dr. Heidi M. Mansour: /* Meeting Abstracts selected from 2006-Present (over 30 abstracts prior to 2006)Presenting Author */

Dr. Heidi M. Mansour: /* Journal Publications Corresponding Author */

Dr. Heidi M. Mansour: /* Journal Publications Corresponding Author */